Wnt/β-catenin signalling in prostate cancer - Nature Reviews Urology

Clicks: 286
ID: 267984
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #4 of 6 articles by views in Nature Reviews Urology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Dysregulation of Wnt signalling, a hallmark of which is the stabilization of the transcriptional co-activator β catenin, can lead to several types of cancer, including prostate cancer. Activation of the Wnt/β catenin pathway has effects on prostate cell proliferation, differentiation and the epithelial–mesenchymal transition. In this Review, the authors discuss how the pathway is activated and consider the possible therapeutic application of drugs that target Wnt/β catenin signalling.
Reference Key
kypta2012naturewnt/β-catenin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Robert M. Kypta;Jonathan Waxman;Robert M. Kypta;Jonathan Waxman;
Journal Nature Reviews Urology
Year 2012
DOI
doi:10.1038/nrurol.2012.116
URL
http://dx.doi.org/10.1038/nrurol.2012.116##access-options
Keywords
gene expression mutation prostate cancer cell signalling gene expression mutation prostate cancer cell signalling gene expression mutation prostate cancer cell signalling

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.